Abstract:More than 1800 gene therapy clinical trials worldwide have targeted a wide range of conditions including cancer, cardiovascular diseases, and monogenic diseases. Biological (i.e. viral), chemical, and physical approaches have been developed to deliver nucleic acids into cells. Although viral vectors offer the greatest efficiency, they also raise major safety concerns including carcinogenesis and immunogenicity. The goal of microbubble-mediated sonoporation is to enhance the uptake of drugs and nucleic acids. Insonation of microbubbles is thought to facilitate two mechanisms for enhanced uptake: first, deflection of the cell membrane inducing endocytotic uptake, and second, microbubble jetting inducing the formation of pores in the cell membrane. We hypothesized that ultrasound could be used to guide local microbubble-enhanced sonoporation of plasmid DNA. With the aim of optimizing delivery efficiency, we used nonlinear ultrasound and bioluminescence imaging to optimize the acoustic pressure, microbubble concentration, treatment duration, DNA dosage, and number of treatments required for in vivo Luciferase gene expression in a mouse thigh muscle model. We found that mice injected with 50μg luciferase plasmid DNA and 5×105 microbubbles followed by ultrasound treatment at 1.4MHz, 200kPa, 100-cycle pulse length, and 540 Hz pulse repetition frequency (PRF) for 2min exhibited superior transgene expression compared to all other treatment groups. The bioluminescent signal measured for these mice on Day 4 post-treatment was 100-fold higher (p<0.0001, n=5 or 6) than the signals for controls treated with DNA injection alone, DNA and microbubble injection, or DNA injection and ultrasound treatment. Our results indicate that these conditions result in efficient gene delivery and prolonged gene expression (up to 21days) with no evidence of tissue damage or off-target delivery. We believe that these promising results bear great promise for the development of microbubble-enhanced sonoporation–induced gene therapies.

Ultrasound and microbubble-assisted gene delivery: recent advances and ongoing challenges

Research of Ultrasound-Mediated Gene Delivery

DNA-loaded Microbubbles with Crosslinked Bovine Serum Albumin Shells for Ultrasound-Promoted Gene Delivery and Transfection

Advances in Microbubble-Assisted Ultrasound-Guided Gene Therapy: Mechanisms and Applications

[Synthesis of New Gene-Loaded Microbubbles Serve As Gene Delivery Vehicle Applied in Reporter Gene Transfer into Cardiac Myocytes].

Multiparameter Evaluation of in Vivo Gene Delivery Using Ultrasound-Guided, Microbubble-Enhanced Sonoporation.

Biogenic Gas Vesicles for Ultrasound Imaging and Targeted Therapeutics

Progress and preclinical application status of ultrasound microbubbles

Ultrasound-responsive microbubbles and nanodroplets: A pathway to targeted drug delivery

Encapsulated ultrasound microbubbles: Therapeutic application in drug/gene delivery

Highlights in ultrasound-targeted microbubble destruction-mediated gene/drug delivery strategy for treatment of malignancies.

Ultrasound-Mediated Drug Delivery: Sonoporation Mechanisms, Biophysics, and Critical Factors

Micelles and nanoparticles for ultrasonic drug and gene delivery

Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy

Sonoporation-induced cell membrane permeabilization and cytoskeleton disassembly at varied acoustic and microbubble-cell parameters

Crucial factors and emerging concepts in ultrasound-triggered drug delivery

Gene Therapy for Ocular Diseases Meditated by Ultrasound and Microbubbles (Review)

Microbubbles and ultrasound: from diagnosis to therapy

Major Strategies for Spatial Control of Ultrasound-Driven Gene Expression to Enhance Therapeutic Specificity.

Vascular Gene Transfer and Drug Delivery in Vitro Using Low-Frequency Ultrasound and Microbubbles

Microsphere as a contrast agent/gene vector in ultrasound imaging-based vascular gene delivery